Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gilbert Donders, Helena Kopp Kallner, Brian Hauck, Anja Bauerfeind, Ann-Kathrin Frenz, Michal Zvolanek & Dale W. Stovall. (2023) Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena® Satisfaction study. The European Journal of Contraception & Reproductive Health Care 28:1, pages 1-9.
Read now
Read now
Articles from other publishers (15)
Elin Stenhammar, Per Wikman, Kristina Gemzell Danielsson, Helena Kopp-Kallner & Inger Sundström Poromaa. (2023) Levonorgestrel intrauterine device and depression: A Swedish register-based cohort study. International Journal of Psychophysiology 193, pages 112230.
Crossref
Crossref
Nelly R. Mugo, Victor Mudhune, Renee Heffron, Katherine K. Thomas, Eleanor McLellan-Lemal, Betty Njoroge, Sue Peacock, Siobhán M. O’Connor, Beatrice Nyagol, Eunice Ouma, Renee Ridzon, Jeffrey Wiener, Nina Isoherranen, David W. Erikson, Louise A. Ouattara, Nazita Yousefieh, Terry A. Jacot, Richard E. Haaland, Susan A. Morrison, Harald S. Haugen, Andrea R. Thurman, Shannon A. Allen, Jared M. Baeten, Taraz Samandari & Gustavo F. Doncel. (2023) Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya. Frontiers in Reproductive Health 5.
Crossref
Crossref
Soyoung Kim, Brian Cicali, Michelle Pressly, Lais Da Silva, Thomas Wendl, Valvanera Vozmediano, Stephan Schmidt & Rodrigo Cristofoletti. (2023) Model-Based Analysis of In Vivo Release Data of Levonorgestrel Implants: Projecting Long-Term Systemic Exposure. Pharmaceutics 15:5, pages 1393.
Crossref
Crossref
Claire E. Knezevic, Teresa L. Parsons, Ryann Gollings, Aashish Pandey & Mark A. Marzinke. (2023) Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 228, pages 115321.
Crossref
Crossref
Mei Heting, Lu Wenping, Wang Yanan, Zhang Dongni, Wu Xiaoqing & Zhuo Zhli. (2023) Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies. Heliyon 9:4, pages e14733.
Crossref
Crossref
Jeffrey T. Jensen, Isabel Reinecke, Teun M. Post, Eeva Lukkari-Lax & Birte M. Hofmann. (2023) Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs. Contraception 120, pages 109954.
Crossref
Crossref
Lueder M. Fels, Dustin Costescu, Carolina S. Vieira, Jeffrey F. Peipert, Eeva Lukkari-Lax, Birte M. Hofmann, Isabel Reinecke, Stefan Klein, Katrin Wiesinger, Bernhard Lindenthal & Runa Speer. (2023) The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial. American Journal of Obstetrics and Gynecology 228:3, pages 322.e1-322.e15.
Crossref
Crossref
Rakhee Sachdeva, Narender Kumar, Vivian Brache, Barbara A. Friedland, Marlena Plagianos, Shimin Zhang, Larisa Kizima, Leila Cochon, Ana Sofía Tejada Tabar, Ann Blanc & Ruth B. Merkatz. (2023) New approaches for developing biomarkers of hormonal contraceptive use. Scientific Reports 13:1.
Crossref
Crossref
Birte Maria Hofmann, Manja Ahola, Lueder M. Fels, Stefan Klein, Bernhard Lindenthal & Jyrki Pihlaja. (2023) Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical Pharmacokinetics 62:1, pages 113-126.
Crossref
Crossref
Danielle M. Harris, Anita Dam, Kate Morrison, Chastain Mann, Ashley Jackson, Shannon M. Bledsoe, Andrea Rowan & Kim Longfield. (2022) Barriers and Enablers Influencing Women's Adoption and Continuation of Vaginally Inserted Contraceptive Methods: A Literature Review. Studies in Family Planning 53:3, pages 455-490.
Crossref
Crossref
Ingrid J.M. Duijkers, Christine Klipping, Tanja Rautenberg, Barbara S. Schug, Prithi S. Kochhar, Hermann Osterwald & Michael Oettel. (2022) Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel. Contraception 110, pages 6-15.
Crossref
Crossref
G. E. Chernukha & V. A. Pronina. (2022) Low-dose intrauterine contraception is an innovative approach to the prevention of unwanted pregnancy. Meditsinskiy sovet = Medical Council:5, pages 40-45.
Crossref
Crossref
Weiqiang Zhu, Junxian Zhang, Xuelian Yuan, Xiaoli Liu, Zhaofeng Zhang, Yanyan Mao, Ying Feng, Ailing Yue, Junjie Sun, Chuan Wen, Jianhua Xu, Yupei Shen, Yan Che & Jing Du. (2021) Whole-exome sequencing reveals novel candidate single nucleotide variations for preventing adverse effects of levonorgestrel implantation. Pharmacogenomics 22:18, pages 1185-1199.
Crossref
Crossref
Robyn L. DwanBritany L. RaymondMichael G. Richardson. (2021) Unanticipated Consequences of Switching to Sugammadex: Anesthesia Provider Survey on the Hormone Contraceptive Drug Interaction. Anesthesia & Analgesia 133:4, pages 958-966.
Crossref
Crossref
Kristina Gemzell-Danielsson, Ali Kubba, Cecilia Caetano, Thomas Faustmann, Eeva Lukkari-Lax & Oskari Heikinheimo. (2021) More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years. BMJ Sexual & Reproductive Health 47:3, pages 228-230.
Crossref
Crossref